Steven T. Rosen

Last updated
Steven T. Rosen
Born
New York City [1]
Alma mater Northwestern University
Scientific career
Fields Oncology, Hematologic malignancies
Institutions City of Hope National Medical Center, Northwestern University, National Cancer Institute
External videos
Nuvola apps kaboodle.svg "Imerman Angels Partnership With City of Hope", Imerman Angels
Nuvola apps kaboodle.svg "City of Hope: Robert Stone, Steven Rosen, and Stephen Forman on advances in cancer research", Charlie Rose

Steven T. Rosen is the executive vice president and director emeritus of City of Hope's Beckman Research Institute and cancer center. [2] He was previously the provost and chief scientific officer of City of Hope National Medical Center in Duarte, California. [3] In addition to previously directing City of Hope's Comprehensive Cancer Center, he also led the Beckman Research Institute at City of Hope and the Irell & Manella Graduate School of Biological Sciences. Previously (1989-2014), Rosen was the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, which was awarded comprehensive cancer center status by the National Cancer Institute (NCI) in 1997.

Contents

In 2015 Rosen received a lifetime achievement award from the Israel Cancer Research Fund (ICRF) for his work in cancer research. His main areas of research involve the development of new treatments, particularly for Hematologic malignancies.

Education

Rosen received his bachelor's degree and medical degree with distinction (1976) [4] from Northwestern University. [5] He was a resident in Internal Medicine at Northwestern. He was a fellow in Medical Oncology at the National Cancer Institute. [4]

Career

Rosen joined City of Hope on March 1, 2014 as its first provost and chief scientific officer. [6] [7] City of Hope has been a Comprehensive Cancer Center since 1998. [8]

Before joining City of Hope, Rosen worked at Northwestern University. He joined Northwestern University in 1981 as a junior faculty member. [1] He was the director of Northwestern University's Robert H. Lurie Comprehensive Cancer Center from 1989 to 2014, [7] [5] and the Genevieve Teuton professor of medicine at the Feinberg School of Medicine. [9] Beginning in 1993, the center at Northwestern received National Cancer Institute (NCI) funding as a designated cancer center in the United States. In 1997, it was awarded comprehensive cancer center status by NCI. [1] [10]

Major areas of focus for his research include 1) the mediation of cancer cell death by glucocorticoids in hematologic malignancies 2) the use of RNA-directed nucleoside analogs in cancer therapy and 3) the role of proteins in cancer metabolism. One of the nucleoside analogs he has worked on is in trials for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia. Rosen has also worked to develop novel treatments for cutaneous lymphoma. [1]

Rosen is the author of more than 450 publications in his field. [11] [5] He is editor-in-chief of the book series Cancer Treatment and Research [12] and Oncology News International. [13]

He has served on a number of boards, including the Board of Directors of the Leukemia & Lymphoma Society (2011-2014), [4] the American Society of Clinical Oncology's Conquer Cancer Foundation [14] [15] [16] and the Scientific Advisory Board of the Multiple Myeloma Research Foundation. [17]

Rosen is an advocate for precision medicine and translational medicine. [18] [19] Under his leadership, City of Hope has partnered with the Translational Genomics Research Institute (TGen). [10]

Other interests

Steven Rosen has four children. [20] [21] He has published a collection of poetry, Stolen moments. [20]

Awards

Related Research Articles

<span class="mw-page-title-main">City of Hope National Medical Center</span> U.S. clinical research center and hospital

City of Hope is a private, non-profit clinical research center, hospital and graduate school located in Duarte, California, United States. The center's main campus resides on 110 acres (45 ha) of land adjacent to the boundaries of Duarte and Irwindale, with a network of clinical practice locations throughout Southern California, satellite offices in Monrovia and Irwindale, and regional fundraising offices throughout the United States.

Emil J. Freireich was an American hematologist, oncologist, and cancer biologist. He was recognized as a pioneer in the treatment of cancer and use of chemotherapy and is often known as the father of modern leukemia therapy.

The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

<span class="mw-page-title-main">Charles Sawyers</span> American physician-scientist (born 1959)

Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.

<span class="mw-page-title-main">Larry Kwak</span> American cancer researcher

Larry Kwak is an American cancer researcher who works at City of Hope in Duarte, California and is the Director of the Toni Stephenson Lymphoma Center at City of Hope. Dr. Kwak formerly worked at the University of Texas MD Anderson Cancer Center. He was included on Time's list of 2010's most influential people.

Minesh P. Mehta is an American radiation oncologist and physician-scientist of Indian origin and Ugandan birth. He is currently deputy director and chief of radiation oncology at Miami Cancer Institute at Baptist Health South Florida.

Eric P. Winer is a medical oncologist and clinical researcher specializing in breast cancer. He is director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital Yale New Haven Health System, effective February 1, 2022. He also is Deputy Dean for Cancer Research at Yale School of Medicine. From 1997 to 2021, he was the Chief of the Breast Oncology Program at Dana–Farber Cancer Institute in Boston, Massachusetts. Beginning in 2013, he held a range of institutional roles at Dana-Farber, including Chief of Clinical Development, the Thompson Chair in Breast Cancer Research and Director of the Dana-Farber/Harvard SPORE in Breast Cancer. He also served as a Professor of Medicine at Harvard Medical School. He was president of the American Society of Clinical Oncology (ASCO) 2022-2023 and became Chair of the Board in mid-June 2023. His career has been focused on breast cancer treatment and research.

<span class="mw-page-title-main">William Kaelin Jr.</span> American Nobel Laureate, Professor of Medicine at Harvard University

William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.

<span class="mw-page-title-main">Elizabeth Jaffee</span> American oncologist

Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.

Maha H. Hussain is the Genevieve E. Teuton Professor of Medicine and deputy director of the Lurie Comprehensive Cancer Center at Northwestern University's Feinberg School of Medicine. She is an oncologist focusing on genitourinary cancers.

Ravi Salgia is a translational thoracic oncologist, clinician/scientist, and academician.

Melissa Andrea Simon is an American clinical obstetrician/gynecologist and scientist who focuses on health equity across the lifespan. Simon is founder and director of the Center for Health Equity Transformation (CHET) in the Feinberg School of Medicine at Northwestern University in Chicago, Illinois, and founder of the Chicago Cancer Health Equity Collaborative, a National Cancer Institute comprehensive cancer partnership led by the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northeastern Illinois University, and the University of Illinois at Chicago. She is the George H. Gardner, MD Professor of Clinical Gynecology, the Vice-Chair of Clinical Research in the Department of Obstetrics and Gynecology, tenured professor of Obstetrics and Gynecology, Preventive Medicine and Medical Social Sciences at Northwestern University Feinberg School of Medicine, and Associate Director of Community Outreach and Engagement at the Robert H. Lurie Comprehensive Cancer Center.

<span class="mw-page-title-main">David Gius</span> American physician-scientist

David R. Gius is an American physician-scientist the Zell Family Scholar Professor, Women's Cancer Research Program director, and Vice Chair of Translational Research at Northwestern University's Feinberg School of Medicine Department of Radiation Oncology and Pharmacology. His research focuses into the mechanistic connection between aging, cellular and/or mitochondrial metabolism, and carcinogenesis focusing on the Sirtuin gene family.

James R. Downing is an American clinical executive. He is the president and chief executive officer of St. Jude Children's Research Hospital.

<span class="mw-page-title-main">Robert H. Lurie Comprehensive Cancer Center</span> Cancer research center in Chicago, Illinois, United States

The Robert H. Lurie Comprehensive Cancer Centerof Northwestern University is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center located on Northwestern Memorial Hospital's downtown medical campus in the Streeterville neighborhood of Chicago, Illinois, United States. One of two NCI-designated cancer centers in Illinois, Lurie Cancer Center's physicians and scientists hold faculty appointments within the Feinberg School of Medicine, Weinberg College of Arts and Sciences, McCormick School of Engineering and Applied Sciences, and other academic units across Northwestern University. Together, they bring their combined knowledge and expertise to patients at Northwestern Memorial Hospital, Ann & Robert H. Children's Hospital of Chicago, Shirley Ryan AbilityLab and the Jesse Brown VA Medical Center. Additionally, Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network and a member of the Big Ten Cancer Research Consortium.

Lori Jo Pierce is an American radiation oncologist and 57th President of the American Society of Clinical Oncology. She is a Full Professor and Vice Provost for Academic and Faculty Affairs at the University of Michigan. Her research focuses on the use of radiotherapy in the multi-modality treatment of breast cancer, with emphasis on intensity modulated radiotherapy in node positive breast cancer, the use of radiosensitizing agents, and the outcomes of women treated with radiation for breast cancer who are carriers of a BRCA1/2 breast cancer susceptibility gene.

Scott Allen Armstrong is an American pediatric oncologist and cancer biologist focused on chromatin-based control of gene expression in cancer and therapeutic discovery. Armstrong and his team were the first to isolate rare leukemia stem cells in a mouse model of leukemia.

<span class="mw-page-title-main">Leonidas Platanias</span> American oncologist

Leonidas C. Platanias is a Greek-American oncologist. He is the Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Jesse, Sara, Andrew, Abigail, Benjamin, and Elizabeth Lurie Professor of Oncology in the Departments of Medicine and Biochemistry and Molecular Genetics.

<span class="mw-page-title-main">Sendurai Mani</span>

Sendurai A. Mani is an Indian-American oncologist and a Molecular Bilogist. He is a fellow of the American Association for the Advancement of Sciences, and Dean's Chair for Translational Oncology at Brown University Warren Alpert Medical School. He is also the associate director for Translational Oncology at the Legorreta Cancer Center at Alpert Medical School, Brown University. Previously, he was a co-director of Metastasis Research Center and co-director, the Center for Stem Cell & Developmental Biology, and a professor of Translational Molecular Pathology at MD Anderson Cancer Center.

Jonathan D. Licht is an American physician who has served as director of the University of Florida Health Cancer Center since 2015, holding The Marshall E. Rinker Sr. Rinker Chair. Licht led the UF Health Cancer Center to achieve designation from the National Cancer Institute in June 2023.

References

  1. 1 2 3 4 Rosen, Steven T (April 2014). "Interview: Cancer-focused research". International Journal of Hematologic Oncology. 3 (2): 109–111. doi:10.2217/ijh.14.6.
  2. ↑ "City of Hope appoints John D. Carpten, Ph.D., as director of its comprehensive cancer center and Beckman Research Institute, and chief scientific officer". PR Newswire. April 6, 2023. Retrieved 24 May 2024.
  3. ↑ Schaefer, Samantha (October 30, 2013). "City of Hope names first provost and scientific director". LA Times. Retrieved 20 September 2017.
  4. 1 2 3 "Steven T. Rosen Elected to Leukemia & Lymphoma Society Board". Robert H. Lurie Comprehensive Cancer Center of Northwestern University. 2011.
  5. 1 2 3 Marquez, Letisia (November 18, 2015). "City of Hope Provost Steven T. Rosen, M.D., honored by Israel Cancer Research Fund". City of Hope. Retrieved 20 September 2017.
  6. ↑ Dennis, Tami (October 31, 2013). "City of Hope Names Steven T. Rosen as Provost/Chief Scientific Officer". Business Wire. Retrieved 20 September 2017.
  7. 1 2 "2015 Tower of Hope Gala". Israel Cancer Research Fund. Retrieved 21 September 2017.
  8. ↑ "City of Hope Comprehensive Cancer Center". NIH National Cancer Institute. 27 July 2012. Retrieved 21 September 2017.
  9. ↑ "Steven Rosen, MD, Accepts Provost Position at City of Hope". Robert F. Lurie Comprehensive Cancer Center. November 11, 2013. Retrieved 21 September 2017.
  10. 1 2 Thornton, Gail S. (May 11, 2017). "City of Hope, Duarte, California – Combining Science with Soul to Create Miracles at a Comprehensive Cancer Center designated by the National Cancer Institute – An Interview with the Provost and Chief Scientific Officer of City of Hope, Steven T. Rosen, M.D." Pharmaceutical Intellignce. Retrieved 21 September 2017.
  11. ↑ pubmeddev. ""st rosen" - PubMed - NCBI". www.ncbi.nlm.nih.gov. Retrieved 2020-01-27.
  12. ↑ "Cancer Treatment and Research". Springer. Retrieved 20 September 2017.
  13. ↑ "Steven Rosen, MD, accepts Editor-in-Chief position for Oncology News International". Cancer Network. January 1, 2008. Retrieved 20 September 2017.
  14. ↑ "Conquer Cancer Foundation Announces Steven T. Rosen, MD, FACP, as Newest Board Member". ASCO Connection. October 29, 2013. Retrieved 21 September 2017.
  15. ↑ "SHOP TALK: Appointments, Promotions, Honors, Grants, & Other 'People News'". Oncology Times. 35 (19): 6–10. 2013. doi: 10.1097/01.COT.0000436602.31443.c8 . Retrieved 22 September 2017.
  16. ↑ "Board of Directors". Conquer Cancer Foundation. Retrieved 22 September 2017.
  17. ↑ "Multiple Myeloma Research Foundation Annual Report 2006" (PDF). Multiple Myeloma Research Foundation. 2006. Retrieved 22 September 2017.
  18. ↑ Rosen, Steven T. (April 2017). "Why Precision Medicine Continues to Be the Future of Health Care". Oncology Times. 39 (7): 24. doi:10.1097/01.COT.0000515944.09948.fc. S2CID   56843644.
  19. ↑ Marquez, Letisia (November 30, 2016). "City of Hope and Translational Genomics Research Institute Combine to Advance Precision Medicine and Speed Translational Research". Business Wire. Retrieved 20 September 2017.
  20. 1 2 Rosen, Steven T. (2011). Stolen Moments: A Collection of Poetry. NOOK Ebook: Lulu Press. ISBN   9780578002347 . Retrieved 20 September 2017.
  21. ↑ Gorenstein, Sarah Preston (October 28, 2011). "The Couple That Heals Together". Michigan Avenue. Retrieved 21 September 2017.
  22. ↑ "Giants of Cancer Care® Program Inductees" . Retrieved 2024-05-28.
  23. ↑ "Steven Rosen Inducted into the AAP". www.cityofhope.org. Retrieved 2020-01-27.
  24. ↑ "Steven Rosen Inducted Into AIMBE College of Fellows - The ASCO Post". www.ascopost.com. Retrieved 2020-01-27.
  25. ↑ "All reward recipients". ASCO. Retrieved 22 September 2017.
  26. ↑ "10th Anniversary Imerman Angels Wings of Hope Gala Raised More Than $375,000". Imerman Angels. Retrieved 21 September 2017.
  27. ↑ "Israel Cancer Research Fund Gala". Daily North Shore. November 30, 2015. Retrieved 21 September 2017.
  28. ↑ "Israel Cancer Research Fund honors City of Hope provost". Healio. November 29, 2015. Retrieved 20 September 2017.
  29. ↑ "Awards & Honors" (PDF). What's New: News of the Lurie Cancer Center. 2011. p. 4. Retrieved 21 September 2017.
  30. ↑ "Nov. 9, 2011 Declared Steven T. Rosen Day in Chicago". Northwestern Memorial Hospital. November 8, 2011. Retrieved 21 September 2017.
  31. 1 2 3 4 Curigliano, Giuseppe; Rosen, Steven T.; Sanson, Marc; Sanz, Miguel A. (November 2014). "Editorial introductions". Current Opinion in Oncology. 26 (6): vii–viii. doi:10.1097/CCO.0000000000000141.
  32. ↑ "Dr. Steven Rosen". Castle Connolly Top Doctors. Castle Connolly Medical Ltd. Retrieved 21 September 2017.
  33. ↑ "Hollywood's Top Doctors: Best Oncologists in Los Angeles". The Hollywood Reporter. 2014-09-19. Retrieved 21 September 2017.
  34. ↑ Administrator, Who's Who Site (2018-05-14). "Steven T. Rosen, MD, FACP, FASCO, FAIMBE". Marquis Who's Who Humanitarian Award. Retrieved 2020-01-27.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.